Preventing HPV-related cervical cancer in women living with HIV in Peru and the Dominican Republic
Colaboracion Evita: HPV-Related Cancer Prevention Partnership Center
This project is testing better HPV vaccine schedules and simpler screening and treatment approaches to help prevent cervical cancer in women living with HIV in Peru and the Dominican Republic.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11400895 on NIH RePORTER |
What this research studies
If you join, you may be offered different HPV vaccine schedules and receive simpler, more affordable cervical screening and treatment options delivered through HIV care clinics. The work is run at clinics in Peru and the Dominican Republic, with data and lab support coordinated from Seattle. Researchers will run three clinical trials to find vaccine and care approaches that fit low-resource settings and the needs of women with HIV. The center also supports labs and data analysis to make sure results are reliable and usable in real clinics.
Who could benefit from this research
Good fit: Ideal candidates are women living with HIV who receive care at participating clinics in Peru or the Dominican Republic and who are eligible for HPV vaccination or cervical screening interventions.
Not a fit: People without HIV, those already treated for invasive cervical cancer, or individuals who cannot attend the participating clinics are unlikely to benefit directly from joining these trials.
Why it matters
Potential benefit: If successful, this work could lower cervical cancer rates and deaths among women living with HIV by improving vaccination and making screening and treatment easier to access.
How similar studies have performed: HPV vaccines work well in the general population and some trials in people with HIV show promise, but the best vaccine schedules and simplified screening approaches for low-resource HIV clinics are not yet well established.
Where this research is happening
Seattle, United States
- Fred Hutchinson Cancer Center — Seattle, United States (Active)
Researchers
- Principal investigator: Madeleine, Margaret M — Fred Hutchinson Cancer Center
- Study coordinator: Madeleine, Margaret M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.